Volume 22 Issue 2, February 2004
News in Brief
Make or break for costimulatory blockers
Immunomodulator CTLA4-Ig was set to be the miracle drug for organ transplantation a dozen years ago, but then faded from view. Now, with startling results in rheumatoid arthritis, costimulatory blockers are on a comeback. Ken Garber reports.
A regulatory patchwork—human ES cell research oversight
Permissive regulations in a few regions of the world are dictating where human embryonic stem (hES) cell research is taking place, but this could change as numerous countries are still formulating policy.
News & Views
Breaching the skin's barrier to drugs
A novel approach for identifying synergistic mixtures of skin penetration enhancers promises to transform development of transdermal products, including patches.
Rather than using bacteriophage themselves as treatments, a new approach recruits them in the search for antibiotics with new antibacterial mechanisms.
Enlightened receptor dynamics
Semiconductor nanocrystals can track movements of individual receptors on the surface of living cells with unmatched spatial and temporal resolution.
The fate of transgenes in the human gut
Gut microbes that cannot be recovered in artificial culture may acquire and harbor genes from genetically modified plants.
Label-free detection becomes crystal clear
Liquid crystalline platforms offer fast, simple and inexpensive detection of incoming analytes on two-dimensional fluid biomembrane mimics.
Genetic sequences: how are they patented?
A survey reveals that the way in which genetic sequences are claimed in granted patents are heterogeneous and imprecise, which may lead to questions regarding their validity.
New on the Market
Careers and Recruitment
Graduate education and employment opportunities in bioethics
As graduate programs in bioethics continue to grow and diversify, picking the right one requires careful planning for one's postgraduate career.